CytRx Announces Agreement with FDA on Special Protocol Assessment for Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin for Soft Tissue Sarcoma

ABCDEFGHIJKLMNOPQRSTUVWXYZ




To view the detailed information, you need to SUBSCRIBE with us.

 screenshot